NVCR vs ROL · rev $357.6M vs P/E 41, rev $1.99B
Novocure Ltd (NVCR) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Novocure Ltd (NVCR) is a medical devices company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported NVCR revenue for 2026-06-30 was $357.6M. Net income was -$86.8M. NVCR currently screens at market cap $1.99B.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
NVCR currently screens at market cap $1.99B. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the NVCR and ROL stock pages for the full models.
Not investment advice.